首页> 外文期刊>Xenotransplantation >Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum
【24h】

Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum

机译:商业酶联免疫吸附测定的交叉验证和非人灵长类动物血清中猪C-肽浓度测量的放射免疫测量

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: C-peptide concentration is widely used as a marker of insulin secretion and is especially relevant in evaluating islet graft function following transplantation, because its measurement is not confounded by the presence of exogenous insulin. To address the shortage of human islet donors, the use of porcine islets has been proposed as a possible solution and the stringent pig-to-non-human primate (NHP) model is often the most relevant for pre-clinical evaluation of the potential for diabetes reversal resulting from an islet xenograft. The Millipore radioimmunoassay (RIA) was exclusively used to measure porcine C-peptide (PCP) until 2013 when the assay was discontinued and subsequently a commercially available enzyme-linked immunosorbent assay (ELISA) from Mercodia has been widely adopted. Both assays have been used in pre-clinical trials evaluating the therapeutic potential of xenograft products in reversing diabetes in the pig-to-NHP model, to interpret data in a comparable way it may be useful to perform a harmonization of C-peptide measurements.
机译:背景:C-肽浓度广泛用作胰岛素分泌的标志物,并且在移植后评估胰岛接枝函数特别相关,因为其测量不会被外源胰岛素的存在混淆。为了解决人体胰岛捐赠者的短缺,已经提出了使用猪胰岛作为可能的解决方案,并且严格的猪对非人类灵长类动物(NHP)模型通常是对临床前评估潜力的最相关的糖尿病逆转由胰岛异种移植物引起的。当停止测定并随后,广泛采用Millipore Radimmunoassay(RIA)直到2013年,从2013年开始测量猪C-肽(PCP)直至2013年。在临床前试验中已用于评估异种移植产品的治疗潜力在猪到NHP模型中逆转糖尿病中的治疗潜力,以以可比的方式解释数据,这对C肽测量进行统一可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号